Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
In a phase 3 trial, oral sebetralstat demonstrated a median time to beginning of symptom relief of 1.61 hours for the 300 mg dose and 1.79 hours for the 600 mg dose, compared to 6.72 hours for placebo in hereditary angioedema attacks.
Allergy & Immunology August 16th 2024
Lemierre’s syndrome, a rare complication of oropharyngeal infections, can lead to severe neurological manifestations such as cavernous sinus thrombosis and cranial nerve palsies.
Emergency Medicine August 15th 2024
Oropharyngeal tularemia can mimic common bacterial pharyngitis, but its rarity and nonspecific symptoms make diagnosis challenging without a high index of suspicion.
Emergency Medicine August 8th 2024
Sweet’s syndrome, a neutrophilic dermatosis that can present with fever and systemic involvement, may be an underrecognized cause of postpartum complications.
Dermatology July 24th 2024
Yellow nail syndrome presents a diagnostic puzzle, with its triad of symptoms potentially occurring asynchronously. Early recognition can lead to appropriate management and improved patient outcomes.
Dermatology July 18th 2024
AL amyloidosis presents a diagnostic challenge due to its varied symptoms, but advancements in therapeutic options, including CyBorD plus daratumumab and emerging antifibril monoclonal antibodies, offer hope for better patient management.
Cardiology July 9th 2024